← Back to headlines
Mineralys Therapeutics (MLYS) Advances with FDA for Hypertension Drug
Mineralys Therapeutics (MLYS) is making progress with the FDA regarding its drug for hypertension.
13 Mar, 18:52 — 13 Mar, 18:52
Sources
Showing 1 of 1 sources
Mineralys Therapeutics (MLYS) is making progress with the FDA regarding its drug for hypertension.
